Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)
Clinical trial NCT04140695 · TERMINATED
Trial details
- NCT number
- NCT04140695
- Sponsor
- Vanda Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-21
- Primary completion
- 2020-10-14
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.